We are live on ! Find out more
BMO

Beck Mack & Oliver Portfolio holdings

AUM $5.13B
1-Year Est. Return 11.51%
This Fund
S&P 500
This Quarter Est. Return
+6.05%
1 Year Est. Return
+11.51%
3 Year Est. Return
+68.19%
5 Year Est. Return
+90.4%
10 Year Est. Return
+384.43%
AUM
$2.85B
AUM Growth
+$49.7M
Cap. Flow
-$75.2M
Cap. Flow %
-2.64%
Top 10 Hldgs %
41.46%
Holding
236
New
11
Increased
27
Reduced
106
Closed
12

Top Buys

Rank Stock Value
1
LUMN icon
Lumen
LUMN
+$11.8M
2
CACC icon
Credit Acceptance
CACC
+$5.56M
3
RDNT icon
RadNet
RDNT
+$4.84M
4
EPD icon
Enterprise Products Partners
EPD
+$3.54M
5
WAB icon
Wabtec
WAB
+$2.7M

Top Sells

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$28.9M
2
QCOM icon
Qualcomm
QCOM
+$10M
3
DOV icon
Dover
DOV
+$6.22M
4
ABT icon
Abbott
ABT
+$3.3M
5
BX icon
Blackstone
BX
+$2.94M

Sector Composition

Rank Sector Weight
1 Financials 30.92%
2 Healthcare 16.7%
3 Technology 13.21%
4 Communication Services 10.46%
5 Industrials 9.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BRC icon
101
Brady Corp
BRC
$4B
$1.06M 0.04%
21,600
– –
VOO icon
102
Vanguard S&P 500 ETF
VOO
$1.04T
$1.04M 0.04%
3,880
– –
CNI icon
103
Canadian National Railway
CNI
$73.7B
$1.03M 0.04%
11,183
– –
DE icon
104
Deere & Co
DE
$184B
$1.03M 0.04%
6,200
– –
CBSH icon
105
Commerce Bancshares
CBSH
$8.39B
$1.01M 0.04%
23,817
– –
AMGN icon
106
Amgen
AMGN
$203B
$995K 0.04%
5,400
– –
BNY
107
Bank of New York Mellon
BNY
$105B
$995K 0.04%
22,528
-22,618
-50% -$1.06M
VWO icon
108
Vanguard FTSE Emerging Markets ETF
VWO
$125B
$995K 0.04%
23,392
– –
BSX icon
109
Boston Scientific
BSX
$63.6B
$993K 0.03%
23,100
– –
EFA icon
110
iShares MSCI EAFE ETF
EFA
$77.9B
$986K 0.03%
15,000
-6,500
-30% -$425K
CSCO icon
111
Cisco
CSCO
$434B
$985K 0.03%
18,000
– –
SJT
112
San Juan Basin Royalty Trust
SJT
$140M
$976K 0.03%
254,800
-192,921
-43% -$854K
PEG icon
113
Public Service Enterprise Group
PEG
$35.1B
$965K 0.03%
16,400
– –
VTI icon
114
Vanguard Morningstar Total Stock Market ETF
VTI
$681B
$956K 0.03%
6,371
-494
-7% -$72.8K
CSL icon
115
Carlisle Companies
CSL
$12.9B
$941K 0.03%
6,700
– –
EW icon
116
Edwards Lifesciences
EW
$49.4B
$931K 0.03%
15,120
-1,200
-7% -$72.6K
WLY icon
117
John Wiley & Sons Class A
WLY
$2.5B
$909K 0.03%
19,822
-430
-2% -$19.6K
LSXMK
118
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
$876K 0.03%
30,271
– –
FOCS
119
DELISTED
Focus Financial Partners Inc. Class A
FOCS
$851K 0.03%
+31,150
New +$1.02M
BMY icon
120
Bristol-Myers Squibb
BMY
$130B
$847K 0.03%
18,674
-2,198
-11% -$102K
MO icon
121
Altria Group
MO
$117B
$834K 0.03%
17,619
-6,216
-26% -$326K
MA icon
122
Mastercard
MA
$502B
$830K 0.03%
3,137
-290
-8% -$72.6K
MCD icon
123
McDonald's
MCD
$179B
$829K 0.03%
3,991
-297
-7% -$58.8K
TSCO icon
124
Tractor Supply
TSCO
$17.2B
$745K 0.03%
34,255
– –
DVN icon
125
Devon Energy
DVN
$56.5B
$737K 0.03%
25,825
-3,600
-12% -$107K
3 4
5
6 7

Similar funds

ACM
AKRE Capital Management Middleburg, Virginia $5.12B AUM 19.08% 1-Year Est. Return
BPCE
Bank Pictet & Cie (Europe) Frankfurt Am Main, Germany $5.12B AUM 27.39% 1-Year Est. Return
SGM
Skye Global Management West Palm Beach, Florida $5.14B AUM 6.88% 1-Year Est. Return
CFO
Callan Family Office Radnor, Pennsylvania $5.11B AUM 35.28% 1-Year Est. Return
SB
SIG Brokerage New York $5.15B AUM 78.53% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
MRCP
Maple Rock Capital Partners Toronto, Ontario, Canada $5.1B AUM 214.22% 1-Year Est. Return
KACA
Kayne Anderson Capital Advisors Los Angeles, California $5.1B AUM 17.16% 1-Year Est. Return

Beck Mack & Oliver's Q2 2019 Portfolio in Review

As of Q2 2019, Beck Mack & Oliver held 236 positions worth $2.85B, up 1.8% from $2.8B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Beck Mack & Oliver's Q2 2019 filing shows 11 new, 27 increased, 106 reduced and 12 closed positions. Its largest new stake was Focus Financial Partners Inc. Class A: 31,150 shares worth $851K. The largest sale was Teva Pharmaceuticals, an estimated $28.9M.

By sector, the portfolio is most concentrated in Financials at 31% of assets, up from 29% a quarter earlier, followed by Healthcare and Technology.

  • Beck Mack & Oliver's largest Q2 2019 buy was Focus Financial Partners Inc. Class A: 31,150 shares worth $851K.
  • Beck Mack & Oliver added most to Lumen in Q2 2019, an estimated $11.8M increase.
  • Beck Mack & Oliver's biggest Q2 2019 reduction was Teva Pharmaceuticals, cutting an estimated $28.9M.
  • Beck Mack & Oliver fully exited Unilever NV New York Registry Shares in Q2 2019, selling an estimated $656K.
  • Beck Mack & Oliver's ten largest holdings make up 41% of its $2.85B portfolio in Q2 2019.
  • Beck Mack & Oliver opened 11 new positions and closed 12 in Q2 2019.
  • Beck Mack & Oliver's portfolio value rose 1.8% quarter-over-quarter to $2.85B.

Based on Beck Mack & Oliver's 13F filing for Q2 2019, filed 13 Aug 2019.